{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:01:50Z","timestamp":1781665310766,"version":"3.54.5"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515110914"],"award-info":[{"award-number":["2023A1515110914"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pancreatic cancer has a poor prognosis, and surgical resection is the only curative option. Extended lymphadenectomy (EPD) during pancreatoduodenectomy may improve staging and reduce recurrence, but its survival benefits over standard lymphadenectomy (SPD) remain controversial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search of PubMed, Embase, Web of Science, and the Cochrane Library was conducted on March 25, 2025. All studies that met the inclusion criteria were subjected to quality assessment and subsequently analyzed by meta-analytical methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nine RCTs involving 1382 patients were analyzed. No significant differences were observed between EPD and SPD in OS (HR = 1.09, <jats:italic>p<\/jats:italic> = 0.384), DFS (HR = 1.08, <jats:italic>p<\/jats:italic> = 0.506), or recurrence (78.05% vs. 79.64%, <jats:italic>p<\/jats:italic> = 0.295). EPD retrieved more positive lymph nodes (MD = 0.66, <jats:italic>p<\/jats:italic> = 0.008), but did not improve prognosis. Postoperative morbidity (38.49% vs. 33.27%, <jats:italic>p<\/jats:italic> = 0.072), mortality (1.97% vs. 1.33%, <jats:italic>p<\/jats:italic> = 0.589), transfusion volume (MD = -31.27, <jats:italic>p<\/jats:italic> = 0.469), and hospital stay (MD = -0.15, <jats:italic>p<\/jats:italic> = 0.917) were comparable, though EPD increased operative time (MD = 53.24, <jats:italic>p<\/jats:italic> &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>EPD reduces lymph node recurrence without improving OS or DFS, suggesting limited prognostic benefit. Its application in pancreatic cancer should be carefully considered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero<\/jats:uri>, identifier CRD42024594566.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1622966","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:33:16Z","timestamp":1751002396000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Outcomes of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic cancer: systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Yu-Chun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.3617","article-title":"International validation of the eighth edition of the american joint committee on cancer (Ajcc) tnm staging system in patients with resected pancreatic cancer","volume":"153","author":"van Roessel","year":"2018","journal-title":"JAMA Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic\u00a0ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann Surg"},{"key":"B4","article-title":"Clinico-pathological study on the appropriate range of pancreatic resection to obtain operative curability of pancreatic head cancer","volume":"85","author":"Ishikawa","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2016.0340","article-title":"A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma","volume":"99","author":"Elshaer","year":"2017","journal-title":"Ann R Coll Surg Engl"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-22-763","article-title":"A more radical perspective on surgical approach and outcomes in pancreatic cancer-a narrative review","volume":"14","author":"Fernandes","year":"2023","journal-title":"J Gastrointest Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-014-2633-9","article-title":"Meta-analysis of the efficacies of extended and standard pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas","volume":"38","author":"Sun","year":"2014","journal-title":"World J Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"E26918","DOI":"10.1097\/MD.0000000000026918","article-title":"Optimal extent of lymphadenectomy for radical surgery of pancreatic head adenocarcinoma: 2-year survival rate results of single-center, prospective, randomized controlled study","volume":"100","author":"Wang","year":"2021","journal-title":"Med (United States)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2022.09.011","article-title":"Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A chinese multi-center prospective randomized controlled trial","volume":"49","author":"Wang","year":"2023","journal-title":"J advanced Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12399","article-title":"Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: A multicenter randomized controlled trial","volume":"43","author":"Lin","year":"2023","journal-title":"Cancer Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomized trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000384","article-title":"A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer","volume":"259","author":"Jang","year":"2014","journal-title":"Ann Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.465","article-title":"Long-term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer: A multicenter prospective randomized controlled study","volume":"24","author":"Jang","year":"2017","journal-title":"J Hepato-Biliary-Pancreatic Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2005.06.044","article-title":"A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma","volume":"138","author":"Farnell","year":"2005","journal-title":"Surgery"},{"key":"B19","article-title":"Standard versus extended lymphadenectomy in radical surgical treatment for pancreatic head carcinoma","volume":"22","author":"Ignjatovic","year":"2017","journal-title":"J BUON"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-011-0466-6","article-title":"Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas","volume":"19","author":"Nimura","year":"2012","journal-title":"J Hepato-Biliary-Pancreatic Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199810000-00007","article-title":"Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study","volume":"228","author":"Pedrazzoli","year":"1998","journal-title":"Ann Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.surg.2014.06.016","article-title":"Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the international study group on pancreatic surgery (Isgps)","volume":"156","author":"Tol","year":"2014","journal-title":"Surgery"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-002-5976-6","article-title":"Results of pancreaticoduodenectomy for pancreatic cancer: extended versus standard procedure","volume":"26","author":"Iacono","year":"2002","journal-title":"World J Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5716","article-title":"Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer","volume":"94","author":"Michalski","year":"2007","journal-title":"Br J Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2019.10.003","article-title":"Efficacy of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic head adenocarcinoma","volume":"19","author":"Wang","year":"2019","journal-title":"Update Meta-Analysis. Pancreatology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"Cd011490","DOI":"10.1002\/14651858.CD011490.pub2","article-title":"Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma","volume":"1","author":"Staerkle","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2005.11.007","article-title":"Local therapy, systemic benefit: challenging the paradigm of biological predeterminism","volume":"18","author":"Kurtz","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25725","article-title":"Changes in total lymphocyte count and neutrophil-to-lymphocyte ratio after curative pancreatectomy in patients with pancreas adenocarcinoma and their prognostic role","volume":"120","author":"Kim","year":"2019","journal-title":"J Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.50.7657","article-title":"Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the espac-3 study","volume":"32","author":"Valle","year":"2014","journal-title":"J Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40880-019-0367-7","article-title":"The efficacy and safety of modified folfirinox as first-line chemotherapy for chinese patients with metastatic pancreatic cancer","volume":"39","author":"Wang","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123866","article-title":"Adjuvant pancreatic cancer management: towards new perspectives in 2021","volume":"12","author":"Turpin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial","volume":"297","author":"Oettle","year":"2007","journal-title":"Jama"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: A phase 3, open-label, randomized, non-inferiority trial (Jaspac 01)","volume":"388","author":"Uesaka","year":"2016","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (Espac-4): A multicenter, open-label, randomized, phase 3 trial","volume":"389","author":"Neoptolemos","year":"2017","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.72.6463","article-title":"Conko-005: adjuvant chemotherapy with gemcitabine plus erlotinib versus gemcitabine alone in patients after R0 resection of pancreatic cancer: A multicenter randomized phase iii trial","volume":"35","author":"Sinn","year":"2017","journal-title":"J Clin Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000000784","article-title":"The more the better-lower rate of stage migration and better survival in patients with retrieval of 20 or more regional lymph nodes in pancreatic cancer: A population-based propensity score matched and trend seer analysis","volume":"46","author":"Warschkow","year":"2017","journal-title":"Pancreas"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1622966\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:33:17Z","timestamp":1751002397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1622966\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":38,"alternative-id":["10.3389\/fonc.2025.1622966"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1622966","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"article-number":"1622966"}}